When the FDA goes after organic substances, it is in part due to big Pharma not wanting competition against their products.
GABA is an effective neuroprotector that works to enhance brain function, and because of this, Eli Lilly made the move to utilize GABA in a drug for Alzheimer’s named Solanezumab. It was then that any natural supplements that were abundant in picamilon, were a huge threat to their $7.6 billion dollar revenue from the Alzheimer’s drug by 2024.
They are ten times more potent than drugs pushed by Big Pharma, so now they are trying to get them approved by the FDA as a medicine. Once the status was being labeled as “investigated as a new drug,” FDA rules explicitly label CBDs as not being a dietary supplement. The FDA has worked on a regulatory campaign of intimidation to push their “problem” away. They sate that CBD products aren’t able to be sold as dietary supplements and even warned CBD marketers.
Who is the FDA really protecting?
This happened with Solanezumab, and with failed results in last stages of clinical trials, people will still be banned access to picamilon.
A good example, extra safety studies are required if a supplement’s target population changes, like when the product being deemed are for adults being prescribed to kids. Toxic drugs like antidepressants and stimulants aren’t put through these regulations, with the FDA acknowledging that most drugs administered to children and the elderly haven’t been routinely tested on those groups.
Instead of the FDA protecting the American people, they are instead choosing Big Pharmaceuticals and their deceptive tactics. The only channel it seems of getting natural healing treatments is through purchasing them from a pharmaceutical company.
If you enjoyed this article or learned something new, please don’t forget to share it with others so they have a chance to enjoy this free information. We believe all information should be free and available to everyone. Have a good day and we hope to see you soon!